logo
Zee shares jump on board's nod to infuse ₹2,237 crore via promoter warrants

Zee shares jump on board's nod to infuse ₹2,237 crore via promoter warrants

Shares of Zee Entertainment Enterprise rose over 3 per cent on Tuesday after it approved raising over ₹2,237 crore from the preferential issue of convertible warrants.
The Mumbai-based broadcaster's stock rose as much as 3.51 per cent during the day to ₹142.7 per share, the steepest advance since June 12 this year. The stock pared gains to trade 1.52 per cent higher at ₹140 apiece, compared to a 0.35 per cent decline in Nifty 50 as of 10:10 AM.
The stock currently trades at the highest level since December 11 last year and has surged over 57 per cent from its March lows. The counter has risen 15.4 per cent this year, compared to a 5.2 per cent fall in the benchmark Nifty 50. Zee Entertainment Enterprises has a total market capitalisation of ₹13,447.27 crore.
Zee to raise over ₹2K crore from preferential issue
The company will raise over ₹2,237 crore from the preferential issue of convertible warrants, as its board of directors on Monday approved the promoters increasing their shareholding in the company.
These warrants are proposed to be allotted to Altilis Technologies or Sunbright Mauritius Investments, according to the stock exchange filing. The promoters' shareholding in the firm will rise to 18.39 per cent from 3.99 per cent.
Before this, the promoter and promoter group, led by Essel Group's Chairman Emeritus, Subhas Chandra, and his family, held 3.99 per cent of the shareholding in the company, according to the Bombay Stock Exchange (BSE).
The Mumbai-based broadcaster also had another meeting with JP Morgan, an investment bank, it stated in its release, where the latter presented an assessment of the company's growth plans and strategic initiatives and also discussed the market perception of the stock and potential alternatives with the board, it said in an exchange filing.
Kotak Securities on Zee fundraise
According to Zee, the capital raise aims to strengthen the core business and potentially fund value-accretive growth opportunities, and increase promoter stake and accountability, Kotak Securities said in a note.
"We have raised our target multiple to 13x (from 12x earlier) and our fair value to ₹127 (from ₹115), but maintain a 'Reduce' rating as we await clarity on the end-use of the growth capital, and a broad-based recovery in the linear TV advertising environment."
Zee Q4 results
The company reported a 14-fold increase in its consolidated net profit to ₹188.4 crore for the January–March quarter (Q4FY25) compared to the same period last year.
The revenue from operations rose marginally by 0.7 per cent year-on-year (Y-o-Y) to Rs 2,184.1 crore in Q4FY25. The modest growth was largely due to a sharp 24.56 per cent decline in advertising revenue, which fell to ₹837.5 crore.
Zee's failed merger with Sony
Last year, Sony Group cancelled the proposed merger of its India media business, Sony Pictures Networks India, now known as Culver Max Entertainment, and Bangla Entertainment, with ZEEL.
The failed merger could have created a $10 billion media entity. The merged entity would have been even bigger than JioStar, the joint venture created after the merger of the media business of Reliance and the India business of global media giant Walt Disney.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IIT Delhi Launches 6-Month Certificate Programme in Data Science And Machine Learning
IIT Delhi Launches 6-Month Certificate Programme in Data Science And Machine Learning

News18

time25 minutes ago

  • News18

IIT Delhi Launches 6-Month Certificate Programme in Data Science And Machine Learning

Last Updated: Through the course, participants will learn about Python, machine learning models, data processing, and interpretation, with a focus on practical use. The Indian Institute of Technology (IIT) Delhi has introduced a Certificate Programme in Data Science and Machine Learning. This six-month online course is aimed at early to mid-career professionals who want to develop strong skills in data analysis, programming, and machine learning for real-world applications. Graduates or diploma holders with at least 50 per cent in Mathematics or Statistics in Class 12, from recognised institutions (UGC/AICTE/DEC/AIU/state or international universities) are eligible to apply for the course. The six month programme will commence on June 29, 2025. Applicants will have to pay a course fee of Rs 1,50,000 plus GST. 'The Indian Institute of Technology Delhi (IIT Delhi) presents a comprehensive six-month online Certificate Programme in Data Science & Machine Learning (DSML). This industry-oriented programme equips participants with the expertise to transform data into actionable insights and build powerful predictive models. Master sought-after skills such as data manipulation, analysis, machine learning algorithms, Python programming, statistics, deep learning, and data visualisation. Whether you're a working professional looking to upskill, a graduate aiming to stand out, or an individual passionate about data analysis, this programme is tailored for you," states the official website. The programme is designed for professionals managing or contributing to software and ML projects, and those seeking to drive data-led innovation in their organisations. Participants will learn about Python, machine learning models, data processing, and interpretation, with a focus on practical use. This programme is best suited for: — Professionals who oversee software development and machine learning projects with a keen interest in developing a data-driven decision-making approach and those looking to apply data science and ML to enhance their business growth Upon scoring at least 50% marks on aggregate in any two out of three quizzes, and maintaining a minimum attendance of 70%, participants will be receive the completion certificate. Those who are unable to achieve 50% marks in the evaluation components, but maintain a minimum of 90% attendance will be awarded a participation certificate. First Published: June 17, 2025, 15:10 IST

Meta teases smart glasses collaboration with Oakley; launch set for June 20
Meta teases smart glasses collaboration with Oakley; launch set for June 20

Time of India

time26 minutes ago

  • Time of India

Meta teases smart glasses collaboration with Oakley; launch set for June 20

Tired of too many ads? Remove Ads Tech major Meta is set to expand its smart glasses portfolio through a new collaboration with eyewear maker Oakley. A new Instagram handle, @oakleymeta, posted a teaser video with the Oakley and Meta logos side by side, much like the branding used for the Ray-Ban Meta smart glasses . The video ended with 'The next evolution is coming on June 20.'Meta CEO Mark Zuckerberg reposted the teaser, adding to the anticipation, other senior executives shared the video as first entered the smart glasses space in 2021 with the launch of Ray-Ban Stories glasses that came with built-in speakers and a camera, but without any augmented reality features. The second-generation version, released in 2023 for $299, added a better camera, improved audio, and an AI like Ray-Ban, is owned by Italy-based eyewear conglomerate EssilorLuxottica. This collaboration is an extension of Meta's existing partnership with the to a report in January by news agency Bloomberg, the Oakley-Meta glasses will be based on the Oakley Sphaera model and may feature a centrally placed built-in camera, unlike the Ray-Ban Meta glasses , where the camera sits on the edge of the frame. Earlier this month Snap Inc., the parent company of ephemeral messaging app Snapchat, announced that it will launch immersive smart glasses called Specs in 2026. This move aligns with other Big Tech players eyeing the lucrative smart eyewear market , as part of their push to make the next big leap in consumer tech hardware.

This homegrown pharma company plans to raise fund
This homegrown pharma company plans to raise fund

India.com

time26 minutes ago

  • India.com

This homegrown pharma company plans to raise fund

इंवेस्टमेंट से पहले रिस्क को जांच लें New Delhi: The upcoming board meeting of Sudarshan Pharma Industries on June 19, 2025, holds significant importance as it will consider and approve the proposal of raising funds. The company may opt for the issuance of equity shares or warrants to raise these funds, as per an exchange filing. The company's statement to the exchanges reads, 'The board of directors of the company will meet on Thursday 19th April, 2025, inter alia, to consider, evaluate and approve the proposal of raising funds by way of issuance of equity shares or any other equity-linked instruments or securities including convertible instruments, warrants etc. subject to applicable approvals.' The shares of Sudarshan Pharma Industries opened with a notable loss of nearly two per cent at Rs 28.82, compared to the previous close of Rs 29.40 on the BSE, underscoring the company's current stock performance. The 52-week high of the stock is Rs 53.50, and the 52-week low is Rs 7.35. The market cap of the company is Rs 693.58. The stock has been falling for the last six days and has fallen 11.3 per cent in the period. This detailed information about the stock's performance provides investors with a comprehensive understanding of the company's current standing. It's worth noting that Sudarshan Pharma Industries' stock is currently trading below the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward market trend. Share Price History The stock has given a multibagger return of 295 per cent in one year and 326 per cent in two years. However, it has corrected over 35 per cent so far this year. Meanwhile, homegrown pharma company Sudarshan Pharma Industries, which manufactures, sources, and distributes chemicals and pharmaceutical products, has informed exchanges that the Government of India has granted it a certificate of recognition – One Star Export House. This prestigious recognition is a testament to the company's commitment to excellence and its contribution to the pharmaceutical industry, making stakeholders feel proud to be associated with Sudarshan Pharma Industries. 'The company has received certificate of recognition – One Star Export House by the Directorate General of Foreign Trade of the Department of Commerce, Ministry of Commerce and Industry, Government of India, and the same shall be valid for a period of 5 years effective from 8th May 2024 up to 31st March 2028,' the company said in an exchange filing. This government certification signifies that the company has demonstrated excellent performance in international trade and achieved a certain level of export performance. It is categorised in five levels, from One Star to Five Star.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store